Risks and benefits of hormone therapy: has medical dogma now been overturned?

References

• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the interventions and postintervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353–68
   PubMed Web of Science ®Google Scholar
• Nabel EG. The Women's Health Initiative – a victory for women and their health. JAMA 2013;310:1349–50
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   Google Scholar
• Department of Health, Education, and Welfare. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington DC: US Government Printing Office, 1964
   Google Scholar
• Hill AB. The environment and disease: association or causation?J Proc R Soc Med 1965;58:295–300
   PubMed Web of Science ®Google Scholar
• Susser M. Causal thinking in the Health Sciences. New York: Oxford University Press, 1979
   Google Scholar
• Susser M. What is a cause and how do we know one?Am J Epidemiol 1991;133:635–48
   PubMed Web of Science ®Google Scholar
• Freedman L, Anderson G, Kipnis V, et al. Guidelines for the statistical monitoring of the Women's Health Initiative clinical trial: April 1,1998. WHI website. Protocol for clinical trial and observational components. Cleo.whi.org/studydoc/consents/whi%20protocol.pdf
   Google Scholar
• Anderson GL. WHI results withstand the test of time. Br Med J Rapid Response BMJ Fri, 2010-93-12 13:47
   Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Shapiro S, Farmer RDT, Mueck AG, Seaman H, Stevenson JC. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. 2. The Women's Health Initiative: estrogen plus progestogen. J Fam Plann Reprod Health Care 2011;37:165–72
   PubMed Web of Science ®Google Scholar
• Hersh AL, Stefanick ML, Stafford RL. National use of menopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47–53
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Chlebowski Rt, Manson JT, et al. Health outcomes after stopping conjugated equine estrogen among postmenopausal women with prior hysterectomy. JAMA 2011; 305:1305–14
   PubMed Web of Science ®Google Scholar
• Shapiro S. Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol 2000;151:939–45
   PubMed Web of Science ®Google Scholar
• IARC Monographs on Carcinogenic Risk to Humans 2004. Tobacco Smoke and Involuntary Smoking. Volume 83. Lyon: International Agency for Research on Cancer (IARC), 2004
   Google Scholar
• Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523–34
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009;360:573–87
   PubMed Web of Science ®Google Scholar
• Study protocol and policies. WHI Manuals 1998;1:1–64 [sect 1]
   Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997;350:1047–59
   PubMed Web of Science ®Google Scholar
• Million Women Study collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003; 362:419–27
   PubMed Web of Science ®Google Scholar
• Stevenson JC, Hodis HN, Pickar JH, Lobo RA. Coronary heart disease and menopause management. The swinging pendulum of HRT. Athersclerosis 2009;207:336–40
   PubMed Web of Science ®Google Scholar
• Maclaren K, Stevenson JC. Primary prevention of cardiovascular disease with HRT. Women's Health 2012;8:63–74
   PubMedGoogle Scholar
• Dietel M, Lewis MA, Shapiro S. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod 2005;20:2052–60
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H, Shapiro S. Risk of breast cancer during hormone therapy: mechanisms. Horm Biol Clin Invest 2010;3:329–39
   PubMedGoogle Scholar
• Petitti DB. Combination estrogen-progestin oral contraceptives. N Engl J Med 2003;349:1443–50
   PubMed Web of Science ®Google Scholar
• De Villiers T, Stevenson JC. The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric 2012;15:263–6
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Hormone replacement therapy – risks and benefits. A review. Am J Epidemiol 2001;30:423–6
   Web of Science ®Google Scholar
• Panay N, Ylikorkola O, Archer DF, et al. Ultra-low dose estradiol and norethisterone acetate: effective menopause symptom relief. Climacteric 2007;10:120–31
   PubMed Web of Science ®Google Scholar